Breaking out, page-9

Kynan ,

longer term the big play is the crop revenue of which a big offtake agreement is already in place with Natura
shorter term we have revenue ramp up on the cosmetic side and the roll out of the cosmetic lines via distributors and hopefully soon enough a online shop. We also have psoriasis final phase testing (over the counter cream ) imminent

I see the Australian strategy as a med term play given the Aust Govt focus beginning to turn to licensed providers of which the company is positioning to be first mover

something for everyone , short med and long !

All IMO DYOR